↓ Skip to main content

Horse chestnut seed extract for chronic venous insufficiency

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
blogs
5 blogs
twitter
23 tweeters
facebook
22 Facebook pages
wikipedia
2 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
154 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Horse chestnut seed extract for chronic venous insufficiency
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd003230.pub4
Pubmed ID
Authors

Max H Pittler, Edzard Ernst

Abstract

Conservative therapy of chronic venous insufficiency (CVI) consists largely of compression treatment. However, this often causes discomfort and has been associated with poor compliance. Therefore, oral drug treatment is an attractive option. This is an update of a Cochrane review first published in 2002 and updated in 2004, 2006, 2008 and 2010.

Twitter Demographics

The data shown below were collected from the profiles of 23 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 154 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
Australia 3 2%
Italy 1 <1%
Russia 1 <1%
Poland 1 <1%
Brazil 1 <1%
Spain 1 <1%
Korea, Republic of 1 <1%
Unknown 142 92%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 33 21%
Researcher 21 14%
Student > Master 19 12%
Student > Ph. D. Student 16 10%
Other 16 10%
Other 46 30%
Unknown 3 2%
Readers by discipline Count As %
Medicine and Dentistry 78 51%
Unspecified 18 12%
Agricultural and Biological Sciences 14 9%
Nursing and Health Professions 12 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Other 20 13%
Unknown 3 2%

Attention Score in Context

This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2019.
All research outputs
#260,383
of 13,533,246 outputs
Outputs from Cochrane database of systematic reviews
#666
of 10,636 outputs
Outputs of similar age
#3,390
of 247,563 outputs
Outputs of similar age from Cochrane database of systematic reviews
#37
of 512 outputs
Altmetric has tracked 13,533,246 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,636 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,563 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 512 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.